Fragment-based drug design and drug repositioning using multiple ligand simultaneous docking (MLSD): identifying celecoxib and template compounds as novel inhibitors of signal transducer and activator of transcription 3 (STAT3). (Q39523484)
Jump to navigation
Jump to search
scientific article published on 8 July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Fragment-based drug design and drug repositioning using multiple ligand simultaneous docking (MLSD): identifying celecoxib and template compounds as novel inhibitors of signal transducer and activator of transcription 3 (STAT3). |
scientific article published on 8 July 2011 |
Statements
1 reference
Fragment-based drug design and drug repositioning using multiple ligand simultaneous docking (MLSD): identifying celecoxib and template compounds as novel inhibitors of signal transducer and activator of transcription 3 (STAT3). (English)
1 reference
Huameng Li
1 reference
Aiguo Liu
1 reference
Zhenjiang Zhao
1 reference
Yufang Xu
1 reference
Jiayuh Lin
1 reference
David Jou
1 reference
Chenglong Li
1 reference
8 July 2011
1 reference
1 reference
54
1 reference
15
1 reference
5592-5596
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference